CLOUD: A phase II study of low-dose nivolumab in first-line metastatic MSI-H/dMMR colorectal cancer (ESMO-IO 2026) - Oct 25, 2026 - Abstract #144P; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available
Clinical • dMMR • Metastases • MSI-H • P2 data • Colorectal Cancer • Microsatellite Instability • Oncology • Solid Tumor • MSI
|
|
Vikas S. Ostwal; Ashwin De Souza; Mufaddal Kazi; Rajiv K. Kaushal; Gauri Deshpande; Omshree Shetty; Avnish Saklani; B Komal Luniya; Tejashree K. Garkal; Pra bhat G. Bhargava; Akshay Baheti; Deepa li Naughane; Lamdeimon Pde; Anura dha Mehta; Subhash Yadav; George John; Anant Ramaswamy
|